ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3,5,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
4,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Headache,Headaches NEC,Headaches,Nerv,N
4,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
5,1,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
6,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
9,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
10,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
12,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,4,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
13,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
16,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
16,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
16,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
17,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
17,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
17,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,Y
17,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,7,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
18,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
19,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
19,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
19,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
21,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
24,3,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,4,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
24,5,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
24,6,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
24,7,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
24,8,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
24,9,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
24,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,12,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
24,13,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
24,14,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
24,15,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
24,16,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
24,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,18,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
24,19,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,20,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,21,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,22,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
24,23,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
24,24,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
24,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
25,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
25,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
25,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,5,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
25,6,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
25,7,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,8,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,9,Blood fibrinogen increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
25,10,Blood immunoglobulin A decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
25,11,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
25,12,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,13,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,14,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,15,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,16,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,17,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
25,18,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
25,19,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,20,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,21,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,22,Granuloma,Inflammations,General system disorders NEC,Genrl,N
25,23,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,24,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,25,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
25,26,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,27,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,28,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,29,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
25,30,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,31,Oedematous kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
25,32,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
25,33,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
25,34,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,35,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,36,Renal tubular atrophy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
25,37,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
25,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Detachment of retinal pigment epithelium,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
26,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
27,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
29,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
29,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
29,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
29,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
29,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
29,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
30,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
30,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
31,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
32,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
34,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,1,Brain stem haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
35,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
35,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
35,4,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
36,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
36,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
36,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
36,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
39,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
39,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
39,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
40,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
42,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
43,3,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
44,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
45,2,Headache,Headaches NEC,Headaches,Nerv,N
45,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
45,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
46,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
46,2,Thalamus haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
47,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
48,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
48,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
49,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
49,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
49,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
52,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
53,1,Headache,Headaches NEC,Headaches,Nerv,N
53,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
53,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
53,4,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
53,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
54,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
54,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
56,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
58,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
59,3,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
60,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
61,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
62,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
64,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
70,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
70,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
70,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
71,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
72,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
72,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
73,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
74,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
75,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
76,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
77,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
77,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
78,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
79,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
80,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,2,Headache,Headaches NEC,Headaches,Nerv,N
80,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
81,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,Adenovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
84,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
84,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
84,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
84,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
84,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
85,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
86,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
86,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
86,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
86,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
87,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
87,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
87,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
88,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
89,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
89,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
89,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
89,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
89,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
90,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
90,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
90,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
90,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
91,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
92,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
92,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
92,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
93,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
96,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
96,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
97,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
98,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
98,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
98,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
98,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
98,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,6,Lividity,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
98,7,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
98,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
98,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
98,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,12,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
98,14,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
99,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
99,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
99,3,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
99,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
99,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
99,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
99,7,Myopathy,Myopathies,Muscle disorders,Musc,N
99,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
100,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
100,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
100,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
101,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
101,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
101,4,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
101,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
101,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
102,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
102,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
102,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
103,1,Detachment of retinal pigment epithelium,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
104,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
104,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
105,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
105,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
106,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
106,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
106,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
106,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
106,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
106,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
107,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
107,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
107,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
108,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
110,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
111,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
112,1,Serous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
112,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
113,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
113,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
115,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
115,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
115,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
115,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
115,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
116,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
116,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
117,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
117,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
118,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
119,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
119,4,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
120,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
121,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
122,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
122,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
122,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
122,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
122,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
122,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
124,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
124,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
125,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
127,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
128,1,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
129,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,2,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
130,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
131,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
131,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
132,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
133,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
134,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
134,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
135,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
137,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,3,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
137,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
137,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Central nervous system melanoma,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
138,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
138,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
138,4,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
139,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
140,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
141,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
141,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
142,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
143,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
143,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
143,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
143,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,7,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
143,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
143,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
143,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
143,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
145,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
145,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
146,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
146,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
146,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
146,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
146,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
147,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
147,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
147,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
147,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
147,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
147,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
147,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
148,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
148,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
148,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
149,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
150,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
151,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
151,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
151,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
152,1,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
153,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
154,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
154,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
154,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
155,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
155,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
156,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
156,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
156,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
156,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
157,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
157,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
157,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
158,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
159,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
159,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
159,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
159,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
160,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
160,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
161,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
161,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
162,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
163,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
163,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
164,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
164,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,1,Band neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
165,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
165,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
165,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
166,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
166,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
168,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
169,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
170,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
171,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
171,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
171,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
173,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
175,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
175,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
176,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
177,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
177,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
178,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
178,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
178,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
179,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
180,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
180,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
181,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
182,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
182,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
183,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
184,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
184,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
185,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
185,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
185,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
185,5,Headache,Headaches NEC,Headaches,Nerv,N
185,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
186,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
186,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
187,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
187,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
187,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
187,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
187,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
188,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
188,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
188,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
188,4,Nerve conduction studies abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
188,5,Neuropathic muscular atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
188,6,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
188,7,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
188,8,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
188,9,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
189,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
189,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,4,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
190,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
190,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
190,3,Headache,Headaches NEC,Headaches,Nerv,N
190,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
191,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
192,1,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
193,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
194,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
194,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
194,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
194,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
195,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
196,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
196,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
196,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
196,4,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
196,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
197,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
197,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
198,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
199,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
199,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
200,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
202,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
203,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
204,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
204,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
204,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
204,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
204,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
204,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
208,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
208,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
208,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
208,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
208,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
208,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,8,Vaginal fistula,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
209,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
209,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
209,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
209,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
209,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
211,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
211,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
211,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
211,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
212,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
212,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
213,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
213,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
213,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
213,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
214,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
214,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
214,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
214,4,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
215,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
215,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
216,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
216,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
216,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
216,4,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
217,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
218,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
218,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
218,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
218,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
218,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
218,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,7,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
219,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
219,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
219,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
219,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
220,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
221,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
221,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
221,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
221,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
222,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
222,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
222,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
222,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
223,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
223,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
223,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
223,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
223,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,7,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
224,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
224,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
224,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
224,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
226,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
226,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
226,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
226,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
226,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
226,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
226,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,8,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
226,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
226,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
227,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
228,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
229,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
230,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
231,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
231,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
231,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
232,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
232,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
233,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
233,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
233,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
234,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
235,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
236,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
237,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
237,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
238,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
238,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
238,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
238,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
239,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
239,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
240,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
240,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
241,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
242,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
243,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
244,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
245,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
245,2,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
245,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
246,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
248,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
248,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
248,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
248,4,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
249,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
249,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
249,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
250,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
250,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
250,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
250,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
250,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
250,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
250,7,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
250,8,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
250,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
250,11,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
250,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
250,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
250,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
250,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
251,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
251,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
251,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
252,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
252,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
252,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
252,5,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
253,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
253,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
253,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
254,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
255,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
255,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
256,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
257,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
257,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
257,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
257,4,Headache,Headaches NEC,Headaches,Nerv,N
258,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
258,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
259,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
259,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
259,3,Gastric polyps,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
259,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
259,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
259,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
259,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
260,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
261,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
261,3,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
262,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
262,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
263,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
263,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
263,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
263,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
263,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
264,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
264,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
264,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
265,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
265,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
265,3,Retinal thickening,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
265,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
266,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
266,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
266,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
266,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
266,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
266,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,7,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
267,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
267,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
268,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
268,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
268,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
269,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
270,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
271,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
271,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
272,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
272,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
272,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
272,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
272,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
272,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
272,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
272,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
272,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
273,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
274,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
274,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
274,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
275,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
275,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
277,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
278,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
278,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
278,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
278,4,Pelvic discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
278,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
278,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
279,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
279,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
279,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
279,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
279,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
279,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
280,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
281,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
281,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
281,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
281,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
282,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
283,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
283,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
284,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,4,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
284,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
284,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
284,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
285,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
285,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
286,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
286,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
286,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
286,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
287,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
287,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
288,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
288,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Headache,Headaches NEC,Headaches,Nerv,N
289,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
290,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
290,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
290,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
290,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
290,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
290,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,1,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
292,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
292,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
293,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
293,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
294,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
294,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
295,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
295,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
295,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
295,4,Headache,Headaches NEC,Headaches,Nerv,N
295,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
295,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
295,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
296,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
296,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,4,Headache,Headaches NEC,Headaches,Nerv,N
296,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
298,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
298,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
299,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
300,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
300,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
300,3,Headache,Headaches NEC,Headaches,Nerv,N
300,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
301,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
301,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
301,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
301,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
302,1,Chorioretinal folds,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
302,2,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
302,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
302,4,Iris adhesions,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
302,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
302,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
302,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
302,8,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
303,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
303,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
303,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
304,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
304,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
305,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
305,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
305,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
305,5,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
306,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
306,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
307,1,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
307,2,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
308,1,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
309,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
310,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
311,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
311,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
311,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
312,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
312,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
312,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
314,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
315,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
315,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
315,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
315,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
316,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
317,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
317,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
317,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
317,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
317,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
318,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
318,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
318,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
318,4,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
318,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
319,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
320,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
321,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
322,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
322,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
322,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
323,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
325,1,Device dislocation,Device issues NEC,Device issues,Prod,N
325,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
325,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
325,5,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
325,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
325,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
326,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
326,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
327,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
327,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
327,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
327,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
328,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
330,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
330,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
330,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
330,4,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
331,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
331,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
333,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
334,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
335,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
335,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
335,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
335,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
335,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
335,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,7,Headache,Headaches NEC,Headaches,Nerv,N
335,8,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
335,9,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
335,10,Myopathy,Myopathies,Muscle disorders,Musc,N
335,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,12,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
335,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
335,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
335,15,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
336,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
336,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
336,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
336,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
337,1,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
337,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
337,3,Myotonic dystrophy,Non-site specific muscle disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
338,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
338,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
338,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
338,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
339,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
339,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
339,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
340,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
340,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
341,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
342,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
342,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
342,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
343,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
344,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
345,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
345,2,Headache,Headaches NEC,Headaches,Nerv,N
346,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
347,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
348,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
348,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
348,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
349,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
351,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
351,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
351,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
352,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
353,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
353,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
354,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
355,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
355,4,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
355,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
355,6,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
355,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
355,8,Teething,Dental disorders NEC,Dental and gingival conditions,Gastr,N
356,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
357,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
357,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
357,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
358,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
358,2,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
358,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
358,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
358,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
359,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
359,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
359,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
360,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
361,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
361,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
361,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
362,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
363,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
364,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
364,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
364,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
365,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
365,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
365,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
366,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
367,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
368,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
368,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
369,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
370,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
370,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
370,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,5,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
370,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Solar lentigo,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
372,1,Corneal lesion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
372,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
372,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
372,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
373,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
373,2,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
373,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
373,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
373,5,Metastases to abdominal cavity,Metastases to specified sites,Metastases,Neopl,N
373,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
374,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
375,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
375,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
376,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
376,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
377,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
377,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
379,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
379,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
379,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
379,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
379,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
379,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
380,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
380,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
380,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
380,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
381,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
381,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
381,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
381,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
381,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
381,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
382,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
383,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
384,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
384,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
384,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
384,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
384,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
385,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
385,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
385,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
385,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
386,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
386,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
386,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
386,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
386,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
387,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
387,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
387,5,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
387,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
387,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
388,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
388,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
388,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
389,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
389,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
389,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
389,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
390,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
390,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
390,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
391,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
391,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
391,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
391,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
392,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
392,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
392,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
393,1,Benign oesophageal neoplasm,Upper gastrointestinal neoplasms benign,Gastrointestinal neoplasms benign,Neopl,N
393,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
394,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
394,3,Ear inflammation,Ear disorders NEC,Aural disorders NEC,Ear,N
394,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
394,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
394,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
394,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
394,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
394,10,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
394,11,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
394,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
394,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
394,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
394,15,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
394,16,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
394,17,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
394,18,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
395,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
395,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
395,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
395,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
395,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
395,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
395,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
395,8,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
395,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
396,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
396,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
396,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
397,1,Choroidal neovascularisation,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
397,2,Retinal white dots syndrome,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
398,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
399,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
399,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
399,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
399,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
400,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
400,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
400,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
400,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
400,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
400,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
400,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
401,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
401,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
401,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
401,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
401,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
402,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
402,2,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
402,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
402,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
403,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
403,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
404,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
404,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
404,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,4,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
404,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
404,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
404,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
404,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
405,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
406,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
407,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
407,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
407,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
407,4,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
407,5,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
407,6,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
407,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
407,8,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
407,9,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
408,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
408,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
408,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
408,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
409,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
409,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
409,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
409,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
410,1,Headache,Headaches NEC,Headaches,Nerv,N
411,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
411,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
411,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
411,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
411,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
413,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
413,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
413,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
415,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
416,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
416,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
417,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
418,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
419,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
420,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
420,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
420,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
